Why be down in the mouth? Three decades of research in oral microbiology

Australian Dental Journal

Volumn 50, Issue 1, 2005, Pages 2-5

  Rogers, A H ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Dental caries; Dental plaque; Oral microbiology; Periodontal diseases

Indexed keywords

BACTERIAL VIRULENCE; DENTAL CARIES; GRAM NEGATIVE BACTERIUM; HUMAN; MOUTH DISEASE; MOUTH FLORA; NONHUMAN; PERIODONTAL DISEASE; REVIEW; STREPTOCOCCUS;

EID: 17744369475     PISSN: 00450421     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1834-7819.2005.tb00078.x     Document Type: Review

References (26)

1. Rogers AH. The proportional distribution and characteristics of streptococci in human dental plaque. Caries Res 1969;3:238-248.
2. Rogers AH. The bacteriocin patterns of strains belonging to various serotypes of Streptococcus mutans. Arch Oral Biol 1976;21:243-249.
3. Davey AL., Rogers AH. Multiple types of the bacterium Streptococcus mutans in the human mouth and their intra-family transmission. Arch Oral Biol 1984;29:453-460.
4. Rogers AH, van der Hoeven JS. Stability of the resident microflora and the bacteriocinogeny of Streptococcus mutans as factors affecting its establishment in specific pathogen-free rats. Infect Immun 1979;23:206-213.
5. Rogers AH, van der Hoeven JS, Zilm PS, de Jong MH. Estimation of growth parameters for some oral bacteria grown in continuous culture under glucose-limiting conditions. Infect Immun 1986;52:897-901.
6. Rogers AH, Zilm PS, Gully NJ. The utilisation of arginine by oral streptococci grown glucose-limited in a chemostat. FEMS Microbiol Letts 1986;37:9-13.
7. Rogers AH, Zilm PS, Gully NJ. The influence of arginine on the co-existence of Streptococcus mutans and Streptococcus milleri in glucose-limited mixed continuous culture. Microb Ecol 1987;14:193-202.
8. Rogers AH, Pfenning AL, Gully NJ, Zilm PS. Factors affecting peptide catabolism by oral streptococci. Oral Microbiol Immunol 1991;6:72-75.
9. 7 in continuous culture. J Gen Microbiol 1990;136:2545-2550.
10. Marsh PD. Sugar, fluoride, pH and microbial homeostasis in dental plaque. Proc Finn Dent Soc 1991;87:515-525.
11. Lewis K. Riddle of biofilm resistance. Antimicrob Agents Chemother 2001;45:999-1007.
12. Bradshaw DJ, Marsh PD, Watson GK, Allison C. Role of Fusobacterium nucleatum and coaggregation in anaerobic survival in planktonic and biofilm oral microbial communities during aeration. Infect Immun 1998;66:4729-4732.
13. Kolenbrander PE, London J. Adhere today, here tomorrow; oral bacterial adherence. J Bacteriol 1993;175:3247-3252.
14. Rogers AH, Chen J, Zilm PS, Gully NJ. The behaviour of Fusobacterium nucleatum chemostat-grown in glucose and amino acid-based chemically defined media. Anaerobe 1998;4:111-115.
15. Bartold PM, Gully NJ, Zilm PS, Rogers AH. Identification of components in Fusobacterium nucleatum chemostat-culture supernatants that are potent inhibitors of human gingival fibroblast proliferation. J Periodontal Res 1991;26:314-322.
16. Rogers AH, Gully NJ, Pfennig AL, Zilm PS. The breakdown and utilization of peptides by strains of Fusobacterium nucleatum. Oral Microbiol Immunol 1992;7:299-303.
17. Rogers AH, Gunadi A, Gully NJ, Zilm PS. An aminopeptidase nutritionally important to Fusobacterium nucleatum. Microbiology 1998;144:1807-1813.
18. Dashper SG, Brownfield L, Slakeski N, Zilm PS, Rogers AH, Reynolds EC. Sodium ion-driven serine/threonine transport in Porphyromonas gingivalis. J Bacteriol 2001;183:4142-4148.
19. Diaz PI, Zilm PS, Rogers AH. The response to oxidative stress of Fusobacterium nucleatum grown in continuous culture. FEMS Microbiol Letts 2000;187:31-34.
20. Diaz PI, Zilm PS, Rogers AH. Fusobacterium nucleatum supports the growth of Porphyromonas gingivalis in oxygenated and carbon-dioxide-depleted environments. Microbiology 2002;148:467-472.
21. Diaz PI, Zilm PS, Wasinger V, Corthals GL, Rogers AH. Studies on NADH oxidase and alkyl hydroperoxide reductase produced by Porphyromonas gingivalis. Oral Microbiol Immunol 2004;19:137-143.
22. Okuda K, Kato T, Ishihara K. Involvement of periodontopathic biofilm in vascular diseases. Oral Dis 2004;10:5-12.
23. Kohler B, Andreen I. Influence of caries-preventive measures in mothers on cariogenic bacteria and caries experience in their children. Arch Oral Biol 1994;39:907-911.
24. Hillman JD. Genetically modified Streptococcus mutans for prevention of dental caries. Antonie Van Leeuwenhoek 2002;82:361-366.
25. Ouwehand AC, Salminen S, Isolauri E. Probiotics: an overview of beneficial effects. Antonie Van Leeuwenhoek 2002;82:279-289.
26. Smith DJ, Taubman MA. Potential for glycosyltransferase-based synthetic peptides in a dental caries vaccine. Adv Exp Med Biol 1995;371:1157-1159.